Chronic stress and antidepressant induced changes in Hdac5 and Sirt2 affect synaptic plasticity

European Neuropsychopharmacology

Volumn 25, Issue 11, 2015, Pages 2036-2048

  Erburu, M ^a   Munoz Cobo I ^a   Dominguez Andres J ^a   Beltran, E ^a   Suzuki, T ^b   Mai, A ^c   Valente, S ^c   Puerta, E ^a   Tordera, R M ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Chronic social defeat stress (CSDS); Histone deacetylase 5 (HDAC5); Imipramine; Major depression; Prefrontal cortex (PFC); Sirt2

Indexed keywords

2 [3 (3 FLUOROPHENETHYLOXY)PHENYLAMINO]BENZAMIDE; 3 [4 [3 (3 FLUOROPHENYL) 3 OXO 1 PROPENYL] 1 METHYL 1H PYRROL 2 YL]ACRYLOHYDROXAMIC ACID; BENZAMIDE DERIVATIVE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; FLUOXETINE; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 10; HISTONE DEACETYLASE 11; HISTONE DEACETYLASE 4; HISTONE DEACETYLASE 5; HISTONE DEACETYLASE 6; HISTONE DEACETYLASE 7; HISTONE DEACETYLASE 8; HISTONE DEACETYLASE 9; HISTONE H3; HISTONE H4; IMIPRAMINE; MESSENGER RNA; PRO BRAIN DERIVED NEUROTROPHIC FACTOR; PROTEIN PRECURSOR; REBOXETINE; SIRTUIN 1; SIRTUIN 2; SIRTUIN 3; SIRTUIN 4; SIRTUIN 5; SIRTUIN 6; SIRTUIN 7; UNCLASSIFIED DRUG; ANTIDEPRESSANT AGENT; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; MORPHOLINE DERIVATIVE; SIRTUIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIPOLAR DISORDER; CHRONIC SOCIAL DEFEAT STRESS; CHRONIC STRESS; CONTROLLED STUDY; CYTOPLASM; DEPRESSION; DOWN REGULATION; DRUG EFFECT; GENE EXPRESSION; HISTONE ACETYLATION; HUMAN; HUMAN TISSUE; MALE; MIDDLE AGED; MORNING DOSAGE; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SOCIAL STRESS; UPREGULATION; ANIMAL; C57BL MOUSE; CHRONIC DISEASE; DRUG EFFECTS; DRUG THERAPY; MENTAL STRESS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; ANIMALS; ANTIDEPRESSIVE AGENTS; CHRONIC DISEASE; DEPRESSIVE DISORDER; FLUOXETINE; HISTONE DEACETYLASE INHIBITORS; HISTONE DEACETYLASES; HUMANS; IMIPRAMINE; MALE; MICE, INBRED C57BL; MIDDLE AGED; MORPHOLINES; NEURONAL PLASTICITY; PREFRONTAL CORTEX; RNA, MESSENGER; SIRTUINS; STRESS, PSYCHOLOGICAL;

EID: 84947494371     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2015.08.016     Document Type: Article

References (55)

1. Banasr M., Chowdhury G.M., Terwilliger R., Newton S.S., Duman R.S., Behar K.L., Sanacora G. Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole. Mol. Psychiatry 2010, 15:501-511.
2. Barros-Minones L., Martin-de-Saavedra D., Perez-Alvarez S., Orejana L., Suquia V., Goni-Allo B., Hervias I., Lopez M.G., Jordan J., Aguirre N., Puerta E. Inhibition of calpain-regulated p35/cdk5 plays a central role in sildenafil-induced protection against chemical hypoxia produced by malonate. Biochim. Biophys. Acta 2013, 1832:705-717.
3. Becker C., Zeau B., Rivat C., Blugeot A., Hamon M., Benoliel J.J. Repeated social defeat-induced depression-like behavioral and biological alterations in rats: involvement of cholecystokinin. Mol. Psychiatry 2008, 13:1079-1092.
4. Beirowski B.1, Gustin J., Armour S.M., Yamamoto H., Viader A., North B.J., Michán S., Baloh R.H., Golden J.P., Schmidt R.E., Sinclair D.A., Auwerx J., Milbrandt J. Sir-two-homolog 2 (Sirt2) modulates peripheral myelination through polarity protein Par-3/atypical protein kinase C (aPKC) signaling. Proc. Natl. Acad. Sci. USA 2011, 25(108):E952-E961.
5. Berton O., McClung C.A., Dileone R.J., Krishnan V., Renthal W., Russo S.J., Graham D., Tsankova N.M., Bolanos C.A., Rios M., Monteggia L.M., Self D.W., Nestler E.J. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 2006, 311:864-868.
6. Covington H.E., Maze I., LaPlant Q.C., Vialou V.F., Ohnishi Y.N., Berton O., Fass D.M., Renthal W., Rush A.J., Wu E.Y., Ghose S., Krishnan V., Russo S.J., Tamminga C., Haggarty S.J., Nestler E.J. Antidepressant actions of histone deacetylase inhibitors. J. Neurosci. 2009, 29:11451-11460.
7. Covington H.E., Vialou V.F., LaPlant Q., Ohnishi Y.N., Nestler E.J. Hippocampal-dependent antidepressant-like activity of histone deacetylase inhibition. Neurosci Lett. 2011, 493:122-126.
8. Creppe C., Malinouskaya L., Volvert M.L., Gillard M., Close P., Malaise O., Laguesse S., Cornez I., Rahmouni S., Ormenese S., Belachew S., Malgrange B., Chapelle J.P., Siebenlist U., Moonen G., Chariot A., Nguyen L. Elongator controls the migration and differentiation of cortical neurons through acetylation of alpha-tubulin. Cell 2009, 136:551-564.
9. Cuadrado-Tejedor M., Hervias I., Ricobaraza A., Puerta E., Perez-Roldan J.M., Garcia-Barroso C., Franco R., Aguirre N., Garcia-Osta A. Sildenafil restores cognitive function without affecting beta-amyloid burden in a mouse model of Alzheimer's disease. Br. J. Pharmacol. 2011, 164:2029-2041.
10. Davidson R.J. Anxiety and affective style: role of prefrontal cortex and amygdala. Biol. Psychiatry 2002, 51:68-80.
11. Derks N.M., Müller M., Gaszner B., Tilburg-Ouwens D.T., Roubos E.W., Kozicz L.T. Housekeeping genes revisited: different expressions depending on gender, brain area and stressor. Neuroscience. 2008, 156:305-309.
12. Dhir A., Kulkarni S.K. Effect of addition of yohimbine (alpha-2-receptor antagonist) to the antidepressant activity of fluoxetine or venlafaxine in the mouse forced swim test. Pharmacology 2007, 80:239-243.
13. Dulac C. Brain function and chromatin plasticity. Nature 2010, 465:728-735.
14. Elizalde N., Garcia-Garcia A.L., Totterdell S., Gendive N., Venzala E., Ramirez M.J., Del Rio J., Tordera R.M. Sustained stress-induced changes in mice as a model for chronic depression. Psychopharmacol. 2010, 210:393-406.
15. Friedmann D.R., Aguilar A., Fan J., Nachury M.V., Marmorstein R. Structure of the alpha-tubulin acetyltransferase, alphaTAT1, and implications for tubulin-specific acetylation. Proc. Natl. Acad. Sci. USA 2012, 109:19655-19660.
16. Gallinari P., Di Marco S., Jones P., Pallaoro M., Steinkuhler C. HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics. Cell Res. 2007, 17:195-211.
17. Germine L.T., Garrido L., Bruce L., Hooker C. Social anhedonia is associated with neural abnormalities during face emotion processing. Neuroimage 2011, 58:935-945.
18. Golden S.A., Christoffel D.J., Heshmati M., Hodes G.E., Magida J., Davis K., Cahill M.E., Dias C., Ribeiro E., Ables J.L., Kennedy P.J., Robison A.J., Gonzalez-Maeso J., Neve R.L., Turecki G., Ghose S., Tamminga C.A., Russo S.J. Epigenetic regulation of RAC1 induces synaptic remodeling in stress disorders and depression. Nat. Med. 2013, 19:337-344.
19. Hobara T., Uchida S., Otsuki K., Matsubara T., Funato H., Matsuo K., Suetsugi M., Watanabe Y. Altered gene expression of histone deacetylases in mood disorder patients. J. Psychiatr. Res. 2010, 44:263-270.
20. Hof P.R., Young W.G., Bloom F.E., Belichenko P.V., Celio M.R. Comparative Cytoarchitectonic Atlas of the C57BL/6 and 129/Sv Mouse Brains 2000, Elsevier, New York.
21. Jochems J., Boulden J., Lee B.G., Blendy J.A., Jarpe M., Mazitschek R., VanDuzer J.H., Jones S., Berton O. Antidepressant-like properties of novel HDAC6-selective inhibitors with improved brain bioavailability. Neuropsychopharmacology 2014, 39:389-400.
22. Keedwell P.A., Andrew C., Williams S.C., Brammer M.J., Phillips M.L. The neural correlates of anhedonia in major depressive disorder. Biol. Psychiatry 2005, 58:843-853.
23. Keller S., Sarchiapone M., Zarrilli F., Videtic A., Ferraro A., Carli V., Sacchetti S., Lembo F., Angiolillo A., Jovanovic N., Pisanti F., Tomaiuolo R., Monticelli A., Balazic J., Roy A., Marusic A., Cocozza S., Fusco A., Bruni C.B., Castaldo G., Chiariotti L. Increased BDNF promoter methylation in the Wernicke area of suicide subjects. Arch. Gen. Psychiatry 2010, 67:258-267.
24. Kendler K.S., Karkowski L.M., Prescott C.A. Causal relationship between stressful life events and the onset of major depression. Am. J. Psychiatry 1999, 156:837-841.
25. Krishnan V., Han M.H., Graham D.L., Berton O., Renthal W., Russo S.J., Laplant Q., Graham A., Lutter M., Lagace D.C., Ghose S., Reister R., Tannous P., Green T.A., Neve R.L., Chakravarty S., Kumar A., Eisch A.J., Self D.W., Lee F.S., Tamminga C.A., Cooper D.C., Gershenfeld H.K., Nestler E.J. Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell 2007, 131:391-404.
26. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2-δδCT method. Methods. 2001, 25:402-408.
27. Mai A., Massa S., Pezzi R., Simeoni S., Rotili D., Nebbioso A., Scognamiglio A., Altucci L., Loidl P., Brosch G. Class II (IIa)-selective histone deacetylase inhibitors. 1. Synthesis and biological evaluation of novel (aryloxopropenyl)pyrrolyl hydroxyamides. J. Med. Chem. 2005, 48:3344-3353.
28. Maxwell M.M., Tomkinson E.M., Nobles J., Wizeman J.W., Amore A.M., Quinti L., Chopra V., Hersch S.M., Kazantsev A.G. The Sirtuin 2 microtubule deacetylase is an abundant neuronal protein that accumulates in the aging CNS. Hum. Mol. Genet. 2011, 20:3986-3996.
29. Mazure C.M., Bruce M.L., Maciejewski P.K., Jacobs S.C. Adverse life events and cognitive-personality characteristics in the prediction of major depression and antidepressant response. Am. J. Psychiatry 2000, 157:896-903.
30. McKinsey T.A., Zhang C.L., Olson E.N. Identification of a signal-responsive nuclear export sequence in class II histone deacetylases. Mol. Cell. Biol. 2001, 21:6312-6321.
31. Meucci O., Scorziello A., Avallone A., Florio T., D'Alto V., Fattore M., Schettini G. Alpha 1 B, but not alpha 1A, adrenoreceptor activates calcium influx through the stimulation of a tyrosine kinase/phosphotyrosine phosphatase pathway, following noradrenaline-induced emptying of IP3 sensitive calcium stores, in PC Cl3 rat thyroid cell line. Biochem. Biophys. Res. Commun. 1995, 209:630-638.
32. Nomura S., Duman R.S., Enna S.J. In vivo or in vitro exposure to imipramine reduces alpha 2-adrenoceptor-mediated inhibition of cyclic AMP production in rat brain cerebral cortical slices. Brain Res. 1987, 410:195-198.
33. North B.J., Marshall B.L., Borra M.T., Denu J.M., Verdin E. The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase. Mol. Cell 2003, 11:437-444.
34. Outeiro T.F., Kontopoulos E., Altmann S.M., Kufareva I., Strathearn K.E., Amore A.M., Volk C.B., Maxwell M.M., Rochet J.C., McLean P.J., Young A.B., Abagyan R., Feany M.B., Hyman B.T., Kazantsev A.G. Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease. Science 2007, 317:516-519.
35. Pandithage R., Lilischkis R., Harting K., Wolf A., Jedamzik B., Luscher-Firzlaff J., Vervoorts J., Lasonder E., Kremmer E., Knoll B., Luscher B. The regulation of SIRT2 function by cyclin-dependent kinases affects cell motility. J. Cell Biol. 2008, 180:915-929.
36. Parra M., Verdin E. Regulatory signal transduction pathways for class IIa histone deacetylases. Curr. Opin. Pharmacol. 2010, 10:454-460.
37. Porcelli S., Salfi R., Politis A., Atti A.R., Albani D., Chierchia A., Polito L., Zisaki A., Piperi C., Liappas I., Alberti S., Balestri M., Marsano A., Stamouli E., Mailis A., Biella G., Forloni G., Bernabei V., Ferrari B., Lia L., Papadimitriou G.N., De Ronchi D., Serretti A. Association between Sirtuin 2 gene rs10410544 polymorphism and depression in Alzheimer's disease in two independent European samples. J. Neural Transm. 2013.
38. Renthal W., Maze I., Krishnan V., Covington H.E., Xiao G., Kumar A., Russo S.J., Graham A., Tsankova N., Kippin T.E., Kerstetter K.A., Neve R.L., Haggarty S.J., McKinsey T.A., Bassel-Duby R., Olson E.N., Nestler E.J. Histone deacetylase 5 epigenetically controls behavioral adaptations to chronic emotional stimuli. Neuron 2007, 56:517-529.
39. Réus G.Z., Abelaira H.M., dos Santos M.A., Carlessi A.S., Tomaz D.B., Neotti M.V., Liranço J.L., Gubert C., Barth M., Kapczinski F., Quevedo J. Ketamine and imipramine in the nucleus accumbens regulate histone deacetylation induced by maternal deprivation and are critical for associated behaviors. Behav Brain Res. 2013, 256:451-456.
40. Rogoz Z. Potentiation of the antidepressant-like effect of desipramine or reboxetine by metyrapone in the forced swimming test in rats. Pharmacol. Rep. 2009, 61:1173-1178.
41. Sando R., Gounko N., Pieraut S., Liao L., Yates J., Maximov A. HDAC4 governs a transcriptional program essential for synaptic plasticity and memory. Cell 2012, 151:821-834.
42. Schroeder F.A., Lin C.L., Crusio W.E., Akbarian S. Antidepressant-like effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse. Biol. Psychiatry 2007, 62:55-64.
43. Sethy V.H., Day J.S., Cooper M.M. Dose-dependent down-regulation of beta-adrenergic receptors after chronic intravenous infusion of antidepressants. Prog. Neuropsychopharmacol. Biol. Psychiatry 1988, 12:673-682.
44. 2 and HDAC6, in the nervous system. Neurochem. Res. 2007, 32:187-195.
45. Sucharov C.C., Dockstader K., Nunley K., McKinsey T.A., Bristow M. beta-Adrenergic receptor stimulation and activation of protein kinase A protect against alpha1-adrenergic-mediated phosphorylation of protein kinase D and histone deacetylase 5. J. Cardiac Fail. 2011, 17:592-600.
46. Suzuki K., Koike T. Mammalian Sir2-related protein (SIRT) 2-mediated modulation of resistance to axonal degeneration in slow Wallerian degeneration mice: a crucial role of tubulin deacetylation. Neuroscience 2007, 147:599-612.
47. Suzuki T., Khan M.N., Sawada H., Imai E., Itoh Y., Yamatsuta K., Tokuda N., Takeuchi J., Seko T., Nakagawa H., Miyata N. Design, synthesis, and biological activity of a novel series of human sirtuin-2-selective inhibitors. J Med Chem. 2012, 55:5760-5773.
48. Taylor D.M., Balabadra U., Xiang Z., Woodman B., Meade S., Amore A., Maxwell M.M., Reeves S., Bates G.P., Luthi-Carter R., Lowden P.A., Kazantsev A.G. A brain-permeable small molecule reduces neuronal cholesterol by inhibiting activity of sirtuin 2 deacetylase. ACS Chem. Biol. 2011, 6:540-546.
49. Tordera R.M., Garcia-Garcia A.L., Elizalde N., Segura V., Aso E., Venzala E., Ramirez M.J., Del Rio J. Chronic stress and impaired glutamate function elicit a depressive-like phenotype and common changes in gene expression in the mouse frontal cortex. Eur. Neuropsychopharmacol. 2011, 21:23-32.
50. Tsankova N.M., Berton O., Renthal W., Kumar A., Neve R.L., Nestler E.J. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat. Neurosci. 2006, 9:519-525.
51. Vega R.B., Harrison B.C., Meadows E., Roberts C.R., Papst P.J., Olson E.N., McKinsey T.A. Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5. Mol. Cell. Biol. 2004, 24:8374-8385.
52. Venzala E., Garcia-Garcia A.L., Elizalde N., Delagrange P., Tordera R.M. Chronic social defeat stress model: behavioral features, antidepressant action, and interaction with biological risk factors. Psychopharmacology 2012, 224:313-325.
53. Venzala E., Garcia-Garcia A.L., Elizalde N., Tordera R.M. Social vs. environmental stress models of depression from a behavioural and neurochemical approach. Eur. Neuropsychopharmacol. 2013, 23:697-708.
54. Volmar C., Wahlestedt C. Histone deacetylases (HDACs) and brain function. Neuroepigenetics 2015, 1:20-27.
55. Wilkinson M.B., Xiao G., Kumar A., LaPlant Q., Renthal W., Sikder D., Kodadek T.J., Nestler E.J. Imipramine treatment and resiliency exhibit similar chromatin regulation in the mouse nucleus accumbens in depression models. J. Neurosci. 2009, 29:7820-7832.